RT Journal Article
SR Electronic
T1 The importance of sustained compliance with physical distancing during COVID-19 vaccination rollout
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.22.21263944
DO 10.1101/2021.09.22.21263944
A1 Teslya, Alexandra
A1 Rozhnova, Ganna
A1 Pham, Thi Mui
A1 van Wees, Daphne A
A1 Nunner, Hendrik
A1 Godijk, Noortje G
A1 Bootsma, Martin
A1 Kretzschmar, Mirjam E
YR 2021
UL http://medrxiv.org/content/early/2021/09/26/2021.09.22.21263944.abstract
AB Mass vaccination campaigns against SARS-CoV-2 are ongoing in many countries with increasing vaccination coverage enabling relaxation of lockdowns. Vaccination rollout is frequently supplemented with advisory from public health authorities for continuation of physical distancing measures. Compliance with these measures is waning while more transmissible virus variants such as Alpha (B.1.1.7) and Delta (B.1.617.2) have emerged. In this work, we considered a population where the waning of compliance depends on vaccine coverage. We used a SARS-CoV-2 transmission model which captures the feedback between compliance, infection incidence, and vaccination coverage to investigate factors that contribute to the increase of the prevalence of infection during the initial stages of the vaccination rollout as compared to no vaccination scenario. We analysed how the vaccine uptake rate affects cumulative numbers of new infections three and six months after the start of vaccination. Our results suggest that the combination of fast waning compliance in non-vaccinated population, low compliance in vaccinated population and more transmissible virus variants may result in a higher cumulative number of new infections than in a situation without vaccination. These adverse effects can be alleviated if vaccinated individuals do not revert to pre-pandemic contact rates, and if non-vaccinated individuals remain compliant with physical distancing measures. Both require convincing, clear and appropriately targeted communication strategies by public health authorities.Significance Statement SARS-CoV-2 vaccination campaigns are in progress in many countries around the world. As the vaccination coverage increases, the compliance with physical distancing measures aimed at reducing virus transmission may decline. Using a socio-epidemiological model we identify factors that are the drivers of increased transmission when SARS-CoV-2 prevalence is higher than the projected prevalence without vaccination. To maximize the benefits of vaccination campaigns, compliance in vaccinated and non-vaccinated groups should be targeted prioritizing one group over the other depending on the vaccination rate, the efficacy of vaccine in blocking the infection, and the circulating variant.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMEK acknowledges support from the Netherlands Organization for Health Research and Development (ZonMw; Grant no. 91216062 and Grant no. 10430022010001). GR acknowledges support from the Portuguese Foundation for Science and Technology (FCT; Grant no. 131\_596787873). AT and HN acknowledge support from the Netherlands Organization for Health Research and Development (ZonMw; Grant no. 91216062).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No oversight was necessary, this is a in-silico mathematical modeling research based on the publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code referred to in the manuscript is deposited in the publicly available repository on GitHub. https://github.com/aiteslya/COVID-19-Vaccine-Compliance